With the completion of project Phase II and Phase III,Donger Pharmaceutical Co.,Ltd. will evolve into a modern pharmaceutical enterprise with research, manufacturing ,sales of traditional Tibetan medicines and high-tech bio-engineering products.Donger will be one of the leaders in Qinghai and national pharmaceutical industry, with fixed asset of RMB 200million,annual sales of RMB 500 million and profit of RMB 100million.

obtaining the advanced technologies and capital support from headquarters in the United States of America,Donger plans to go pubic in American stock market taking the advantages of manufacturing operation and financial operation.Furthermore,the sales network and professional marketing team brings our consumers not only quality products and services,but also the new concept of health.Donger holds the notion of "Repaying the Society".With the expanding charitable activities and more market shares,Donger will deliver evangels of health and happiness to more families.